NCT05041595View on ClinicalTrials.gov

Lyme Disease Diagnostic Assay - Collection of Whole Blood

Enrolling by invitationOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

December 31, 2024

Conditions
Lyme DiseaseHealthy
Interventions
DIAGNOSTIC_TEST

Lyme diagnostic assay

Serological and immunoresponse assay

Trial Locations (1)

55082

DiaSorin Inc., Stillwater

Sponsors

Lead Sponsor

DiaSorin Inc.
All Listed Sponsors
lead

DiaSorin Inc.

INDUSTRY

NCT05041595 - Lyme Disease Diagnostic Assay - Collection of Whole Blood | Biotech Hunter | Biotech Hunter